A detailed history of Advisor Group Holdings, Inc. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 44 shares of TBPH stock, worth $430. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 232 81.03%
Holding current value
$430
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$7.66 - $10.25 $1,440 - $1,927
-188 Reduced 81.03%
44 $0
Q2 2024

Aug 13, 2024

BUY
$8.29 - $9.92 $779 - $932
94 Added 68.12%
232 $1,000
Q1 2021

May 13, 2021

SELL
$16.57 - $21.08 $1,292 - $1,644
-78 Reduced 36.11%
138 $3,000
Q3 2020

Nov 12, 2020

SELL
$14.79 - $22.49 $147 - $224
-10 Reduced 4.42%
216 $3,000
Q1 2020

May 18, 2020

BUY
$17.84 - $31.21 $4,031 - $7,053
226 New
226 $5,000

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $654M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.